Epstein–Barr Virus Infection and Multiple Sclerosis: A Review
- 2.2k Downloads
Epstein–Barr virus (EBV) infection results in a life-long persistence of the virus in the host’s B-lymphocytes and has been associated with numerous cancers including Burkitt’s lymphoma, Hodgkin lymphoma, and nasopharyngeal carcinoma. There is considerable evidence that EBV infection is a strong risk factor for the development of multiple sclerosis. Early age at primary EBV infection is typically asymptomatic, but primary infection during adolescence or adulthood often manifests as infectious mononucleosis, which has been associated with a two- to threefold increased risk of MS. Most importantly, MS risk is extremely low in individuals who are EBV negative, but it increases several folds following EBV infection. Additional evidence supporting a role for EBV in MS pathogenesis includes the observations of elevated antibodies to EBV antigens (especially EBV nuclear antigen-1) prior to the onset of MS, and an increased risk of MS among EBV-positive children. The biological mechanism by which EBV may cause MS is not known, but several possibilities are discussed.
KeywordsEpstein–Barr virus multiple sclerosis infection
We thank Ms. Leslie Unger for technical assistance in the preparation of this manuscript.
The authors have no conflicts of interest to disclose.
- Ascherio A, Munger KL (2010) Epidemiology of multiple sclerosis: environmental factors, In: Luchinetti and Hohlfeld, eds. Multiple Sclerosis 3, 1st ed. Philadelphia: Saunders, Elsevier 57–82. Copyright © 2010 Elsevier. All rights reservedGoogle Scholar
- Kieff ED, Rickinson AB (2007) Epstein–Barr virus and its replication. In: Knipe DM et al (eds) Fields virology, vol 2, 5th edn. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, pp 2603–2654Google Scholar
- Levin LI et al (2010) Primary infection with the Epstein–Barr virus and risk of multiple sclerosis. Ann Neurol. doi: 10.1002/ana.21978
- Peferoen LA et al (2009) Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain. doi: 10.1093/brain/awp296
- Rickinson AB, Kieff E (2007) Epstein–Barr virus. In: Knipe DM et al (eds) Fields virology, vol 2, 5th edn. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, pp 2655–2700Google Scholar
- Sargsyan SA et al (2010) Absence of Epstein–Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology. doi: 10.1212/WNL.0b013e3181d865a1
- Sokal EM et al (2007) Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein–Barr virus vaccine in healthy young adults. J Infect Dis 196(12):1749–1753CrossRefPubMedGoogle Scholar